Immunovant Files Form 4 for Ownership Changes
Ticker: IMVT · Form: 4 · Filed: 2026-04-09T16:31:14-04:00
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Immunovant filed a Form 4 on 4/9/26 for ownership changes on 4/7/26.
AI Summary
On April 9, 2026, Immunovant, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The report covers transactions that occurred on April 7, 2026. The filing was accepted by the SEC on April 9, 2026.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of ownership changes and does not inherently indicate new risks for the company.
Key Numbers
- 0001764013-26-000052 — SEC Accession Number (Unique identifier for the filing)
Key Players & Entities
- Immunovant, Inc. (company) — Issuer
- 0001764013 (company) — Issuer CIK
- 2026-04-09 (date) — Filing Date
- 2026-04-07 (date) — Period of Report
- ROIVANT SCIENCES LTD. (company) — Mailing Address
FAQ
What type of SEC filing is this?
This is a Form 4, a Statement of changes in beneficial ownership of securities.
When was the filing date?
The filing date was April 9, 2026.
What period does this report cover?
The period of report is April 7, 2026.
Who is the issuer of this filing?
The issuer is Immunovant, Inc.
What is the CIK number for Immunovant, Inc.?
The CIK number for Immunovant, Inc. is 0001764013.
From the Filing
EDGAR Filing Documents for 0001764013-26-000052 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001764013-26-000052 Filing Date 2026-04-09 Accepted 2026-04-09 16:31:14 Documents 1 Period of Report 2026-04-07 Document Format Files Seq Description Document Type Size 1 FORM 4 wk-form4_1775766671.html 4 1 FORM 4 wk-form4_1775766671.xml 4 6107 Complete submission text file 0001764013-26-000052.txt 7696 Mailing Address C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON United Kingdom SW1H 0DB Business Address Torti Frank ( Reporting ) CIK : 0001647805 (see all company filings) Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 26852021 Mailing Address 1000 PARK FORTY PLAZA DURHAM NC 27713 Business Address 1000 PARK FORTY PLAZA DURHAM NC 27713 917-410-3120 Immunovant, Inc. ( Issuer ) CIK : 0001764013 (see all company filings) EIN. : 832771572 | State of Incorp.: DE | Fiscal Year End: 0331 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)